PLSE
Pulse Biosciences Inc

1,937
Mkt Cap
$1.22B
Volume
0.00
52W High
$25.00
52W Low
$13.77
PE Ratio
-17.13
PLSE Fundamentals
50D MA
$16.97
Beta
1.22
Avg. Volume
226,072.05
EPS (Annual)
-$0.9176
P/B
11.64
Rev/Employee
$0.00
Loading...
Loading...
Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Miami, FL.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
75

Frequently Asked Questions

What is Market Cap of Pulse Biosciences Inc?
What is the 52-week high for Pulse Biosciences Inc?
What is the 52-week low for Pulse Biosciences Inc?
What is the PE ratio of Pulse Biosciences Inc?
What is the Price-to-Book ratio of Pulse Biosciences Inc?
What is the 50-day moving average of Pulse Biosciences Inc?
How many employess does Pulse Biosciences Inc has?

Latest PLSE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.